{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:46:39Z","timestamp":1792035999241,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clbc.2026.08.018","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:43:31Z","timestamp":1787701411000},"page":"97-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ultra-Hypofractionated Whole-Breast Irradiation: Real-World Data From a Prospective Single-Institution Cohort"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8746-3814","authenticated-orcid":false,"given":"Olga","family":"Unterkirhere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino","family":"Streller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Logaritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dubsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Glanzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Studer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10237","key":"10.1016\/j.clbc.2026.08.018_bib0001","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.018_bib0002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13014-025-02669-w","article-title":"Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020-2023, using registry data and questionnaires","volume":"20","author":"Eijkelboom","year":"2025","journal-title":"Radiat Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2026.08.018_bib0003","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clon.2022.03.001","article-title":"From 25 fractions to five: how hypofractionation has revolutionised adjuvant breast radiotherapy","volume":"34","author":"Yarnold","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clbc.2026.08.018_bib0004","article-title":"DEGRO statement on the FAST-Forward trial: 10-year data of ultrahypofractionated radiation therapy for breast cancer","author":"Matuschek","year":"2025","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.018_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00066-020-01744-3","article-title":"Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: considerations regarding FAST and FAST-Forward","volume":"197","author":"Krug","year":"2021","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1016\/j.clbc.2026.08.018_bib0006","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clon.2020.03.006","article-title":"International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic","volume":"32","author":"Coles","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clbc.2026.08.018_bib0007","article-title":"Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands","volume":"47","author":"Eijkelboom","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2026.08.018_bib0008","article-title":"Single-institution prospective evaluation of moderately hypofractionated whole-breast radiation therapy with simultaneous integrated boost with or without lymphatic drainage irradiation after breast-conserving surgery","volume":"8","author":"Unterkirhere","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clbc.2026.08.018_bib0009","article-title":"Early and intermediate treatment outcome after postoperative external beam accelerated partial breast irradiation in patients with early-stage breast cancer","author":"Stenger-Weisser","year":"2023","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2026.08.018_bib0010","article-title":"Tolerance of adjuvant ultrahypofractionated whole-breast radiation therapy employing moderately hypofractionated sequential boost: a single institution analysis","volume":"10","author":"Unterkirhere","year":"2025","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.018_bib0011","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2011.06.026","article-title":"First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE\/04\/015)","volume":"100","author":"Agrawal","year":"2011","journal-title":"Radiother Oncol"},{"issue":"28","key":"10.1016\/j.clbc.2026.08.018_bib0012","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.19.02750","article-title":"Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer","volume":"38","author":"Brunt","year":"2020","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2026.08.018_bib0013","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1245\/s10434-019-08160-7","article-title":"Validation of a novel nomogram for prediction of local relapse after surgery for invasive breast carcinoma","volume":"27","author":"Corso","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.018_bib0014","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2015.12.027","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1","volume":"118","author":"Offersen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2026.08.018_bib0015","unstructured":"The Institute of Cancer Research. FAST-Forward. Randomised clinical trial testing a 1-week course of curative whole breast radiotherapy against a standard 3-week schedule in terms of local cancer control and late adverse effects in patients with early breast cancer. Version 5.1 05\/02\/2018. [Internet]. Available from: https:\/\/www.icr.ac.uk\/media\/docs\/default-source\/default-document-library\/fast-forward-protocol.pdf?sfvrsn=421a2169_0. Accessed: August 20, 2024."},{"key":"10.1016\/j.clbc.2026.08.018_bib0017","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). [Internet]. Available from: http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm. Accessed: November 25, 2025."},{"key":"10.1016\/j.clbc.2026.08.018_bib0018","doi-asserted-by":"crossref","unstructured":"LENT SOMA tables. Radiother Oncol 1995;35(1):17\u201360.","DOI":"10.1016\/0167-8140(95)90055-1"},{"issue":"2","key":"10.1016\/j.clbc.2026.08.018_bib0019","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0360-3016(79)90729-6","article-title":"Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast","volume":"5","author":"Harris","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.018_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41598-019-57094-3","article-title":"The prognostic and predictive potential of Ki-67 in triple-negative breast cancer","volume":"10","author":"Zhu","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.clbc.2026.08.018_bib0021","doi-asserted-by":"crossref","first-page":"e1141","DOI":"10.1016\/j.clbc.2025.08.007","article-title":"Real world safety of adjuvant ultra hypofractionated radiotherapy in nonmetastatic breast cancer: acute cutaneous toxicity and aesthetic outcomes","volume":"25","author":"Mezghani","year":"2025","journal-title":"Clin Breast Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:06:35Z","timestamp":1792033595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1526820926001552"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.018","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultra-Hypofractionated Whole-Breast Irradiation: Real-World Data From a Prospective Single-Institution Cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}